Collector
Giriş Yap
Sun Pharma will continue investing in R&D after organon deal: CFO Jayashree Satagopan | Collector
Sun Pharma will continue investing in R&D after organon deal: CFO Jayashree Satagopan

Sun Pharma will continue investing in R&D after organon deal: CFO Jayashree Satagopan

Sun Pharma expects strong cash flows from the combined business to support debt reduction, innovation investments and growth across specialty medicines, women’s health and global markets.

Go to News Site